AGP Picks
View all

The Boston Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Boston Examiner.

Press releases published on July 21, 2026

AgZen Wins CropLife Ag-Tech Award of Excellence and Announces the Launch of 200+ Dealer Locations as Grower Demand for RealCoverage® Surges
NetBox Labs and BlueAlly Announce Strategic Partnership to Drive Network Automation and Infrastructure Transformation
Advisor360° Appoints Ananya Balaram as Chief Revenue Officer to Accelerate Next Phase of Growth
Azurity Announces Plans to Commercialize D-PLEX100 in the U.S. and Canada through Exclusive Partnership with PolyPid
CCC Named to KMWorld’s 2026 AI 100 List of Intelligent Knowledge Management Solution Providers
Innomotics Selects Anaqua to Power Global IP Management
Exascale Labs $300 Million Customer Pipeline Advancing Across AI Infrastructure and GPU-As-A-Service Business Lines
Flywire to Announce Second Quarter 2026 Earnings on August 4, 2026
Alpha Tau Reports Positive Data Demonstrating 100% Objective Response Rate and 18.2-Month Median Overall Survival with Alpha DaRT® in Combination with Pembrolizumab in Locally Advanced or Metastatic Head and Neck Cancer, Surpassing the Study's…
Microbot Medical® Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting
Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
IPG Photonics to Announce Second Quarter 2026 Financial Results on August 4
Lakeside Software Named a Leader in ISG’s Provider Lens™ Evaluations for Digital Employee Experience and AI-Enabled End-User Computing Solutions 2026
Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics
New York Times Bestselling Author, Psychiatrist to Hunter Biden, and Executive Coach Keith Ablow Explores Radical Reinvention in New Novel
Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026
Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease
Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Boston Examiner

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.